Sunday, November 17, 2019
Breaking Medical Device Industry News
Home Owlstone Medical

Owlstone Medical

    Owlstone Medical Partners with Thermo Fisher Scientific

    The collaboration seeks to advance the application of non-invasive breath sampling to address the challenges of the early detection of disease and the precision medicine delivery of healthcare through the discovery and validation of novel biomarkers

    Breath Biopsy Kits Launched by Owlstone Medical

    3/28/18: Commercially available research kits extend access to Breath Biopsy technology for discovery of VOC biomarkers in early disease detection and precision medicine

    Owlstone Medical and Cancer Research UK (CRUK) Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease

    Owlstone Medical, (diagnostics company developing a breathalyzer for disease), today announced the initiation of the PAN Cancer trial for Early Detection of Cancer in...

    Owlstone Medical CEO and Breath Biopsy Pioneer Billy Boyle wins Royal Academy of Engineering’s Silver Medal

    Billy Boyle, Founder and CEO of Owlstone Medical, (a diagnostics company developing a breathalyzer for disease), is to be awarded the Royal Academy of...

    Owlstone Medical Establishes Scientific Advisory Board with Appointment of Professor Sir Bruce Ponder

    Billy Boyle, co-founder and CEO at Owlstone Medical, commented: “With over four decades’ work in cancer research we are honoured that Professor Sir Bruce...

    Owlstone Medical and Mayo Clinic Collaborate to Develop Pre-Endoscopic Test to Improve Effectiveness of Colonoscopy

    Pilot study demonstrates FAIMS technology is able to detect patients inadequately prepped prior to colonoscopy with 100% sensitivity Owlstone Medical, a diagnostics company developing a...